Amondys 45
Total Payments
$4.8M
Transactions
223
Doctors
8
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.4M | 62 | 3 |
| 2023 | $1.3M | 51 | 6 |
| 2022 | $1.4M | 52 | 1 |
| 2021 | $666,719 | 58 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.6M | 210 | 54.6% |
| Royalty or License | $2.2M | 6 | 45.4% |
| Food and Beverage | $127.96 | 7 | 0.0% |
Payments by Type
Research
$2.6M
210 transactions
General
$2.2M
13 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 4045-301 | Sarepta Therapeutics, Inc. | $2.6M | 1 |
| 4045-302 | Sarepta Therapeutics, Inc. | $1,500 | 1 |
Top Doctors Receiving Payments for Amondys 45
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Atlanta, GA | $4.8M | 209 |
| , MD | Nephrology | Miami, FL | $10,500 | 7 |
| , CPNP | Nurse Practitioner | Holbrook, NY | $22.60 | 1 |
| , M.D | Pediatric Cardiology | Stony Brook, NY | $22.60 | 1 |
| , NP | Family | New Hyde Park, NY | $22.59 | 1 |
| Akram Mirdamadiha | Family | Plano, TX | $15.90 | 1 |
| , MD | Student in an Organized Health Care Education/Training Program | Sherman, TX | $15.90 | 1 |
| Melissa Lee | Pediatrics | Hartford, CT | $14.19 | 1 |
| , MD | Pediatric Emergency Medicine | Hartford, CT | $14.18 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $4.8M
- Total Doctors 8
- Transactions 223
About Amondys 45
Amondys 45 is a drug associated with $4.8M in payments to 8 healthcare providers, recorded across 223 transactions in the CMS Open Payments database. The primary manufacturer is Sarepta Therapeutics, Inc..
Payment data is available from 2021 to 2024. In 2024, $1.4M was paid across 62 transactions to 3 doctors.
The most common payment nature for Amondys 45 is "Unspecified" ($2.6M, 54.6% of total).
Amondys 45 is associated with 2 research studies, including "4045-301" ($2.6M).